Currently, medicine in general and diagnostics in particular are characterized by imaging procedures.

With our hyperspectral imaging systems TIVITA® Tissue and TIVITA® Wound we offer an innovative imaging method for physicians and clinicians, which enable a non-invasive chemical analysis of recorded tissue samples with a matter of seconds.

“With the advancement of hardware technologies, image analysis methods, and computational power, we expect that HSI will play an important role for noninvasive disease diagnosis and monitoring, identification and quantitative analysis of cancer biomarkers, image-guided minimum invasive surgery, targeted drug delivery and tracking, and pharmaceutical drug dosage assessment.”

[Lu, Guolan, and Baowei Fei. “Medical hyperspectral imaging: a review.” Journal of biomedical optics 19.1 (2014): 010901-010901.]

“These intrinsic NIR optical properties of tissue can be exploited to provide information on perfusion, tissue oxygenation, vascular compliance, angiogenesis, and the structural characteristics of the extracellular matrix. All of these are relevant to the healing wound.”
[Sowa, Michael G., et al. “Review of near-infrared methods for wound assessment.” Journal of biomedical optics 21.9 (2016): 091304-091304.]

„Traditionally, chronic wound infection is diagnosed by visual inspection under white light and microbiological sampling, which are subjective and suboptimal, respectively, thereby delaying diagnosis and treatment.“

[DaCosta, Ralph S., et al. “Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results.” PloS one 10.3 (2015): e0116623.]